Sitemap
- Cookie Policy - Cookie Policy
- Terms of Use - Terms of Use
- Email & Phone subscription PDPN
- My Account
- Science
- Cutting Edge Science
- Benign Prostate Hyperplasia (BPH)
- Neurology
- Cardiovascular
- Thrombosis
- Rethinking CAT Management: From Evidence to Expert Guidance
- From Algorithms to Action: AI Tools Optimizing VTE Management
- VTE Risk in Gynecologic Cancers: Key Insights for Safer Patient Outcomes
- Unmasking the Hidden Threat: VTE in Lung Cancer
- Understanding Cancer-Associated Thrombosis: A Critical Approach to Patient Care
- Optimizing Antithrombotic Therapy & Managing VTE Risk in Cancer Patients
- Managing Venous Thromboembolism in Cancer Patients: Key Insights on Prevention and Risk Factors
- Enhancing VTE Prophylaxis in Medically Ill Patients: Bridging the Gap in Clinical Practice
- The Impact and Future of Pulmonary Embolism Response Teams (PERTs)
- Advances in DVT Intervention: Key Insights from Recent Studies
- Latest Insights in Managing Venous Thromboembolism in Cancer Care
- Insights into Enoxaparin Therapy for High-Risk Patients
- Management of Anticoagulant-Related Bleeding in VTE
- Unveiling the Timeline: Major Surgery, VTE Events, and Prolonged LMWH Use
- Advancements in Risk Assessment for VTE associated with Cancer & Hospitalization
- Navigating Complexities in Anticoagulation: Insights for Optimal Management
- Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for world thrombosis day
- Effective and safe dose of enoxaparin for the treatment of cancer associated thrombosis: Subgroup analyses of RIETECAT
- Thromboprophylaxis in Covid-19 patient by Prof. Carrier. Interactive interview.
- Prof Le Gal's session "Thromboprophylaxis in acute medical illness"
- Risk-stratified thromboprophylaxis in special patient groups
- Real-world in-hospital antiplatelet-switching strategy after coronary interventions: The SWITCH study
- Association of extended anticoagulation therapy with risk of recurrent VTE and bleeding rates in cancer-associated VTE
- Current practice in VTE management in medically ill patients
- In general surgical patients, the risk of VTE continue to exist after discharge
- Physician’s recommendation is a key for patients adherence to VTE treatment.
- Dyslipidemia
- Lipid Assessment, Treatment Optimization and Adherence in ASCVD Patients
- Lipid Insights: PCSK9 Inhibitors, TyG Index, and Cardiovascular Health
- Recent Updates in Cardiovascular Therapeutic Interventions
- New Horizons in Cardiovascular Research: Transformative Insights for Enhanced Patient Care
- PCSK9 Inhibitors and Their Impact on Cardiovascular Risk Management
- Charting New Horizons in Cardiovascular Care: Unveiling Insights from ESC 2023
- Lp(a) in clinical practice - Risk estimation and how to reduce its associated risk: A European Atherosclerotic Society consensus statement
- Routine early treatment with PCSK9i
- Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated
- Impact of ESC/EAS 2019 dyslipidemia guidelines on LDL-C goal achievement in ACS patients: The ACS EuroPath IV project
- Treatment gaps in lipid management among high- and very high-risk patients in Europe: The SANTORINI study
- Persistence, effectiveness, and impact on quality of life with long-term PCSK9 inhibitor treatment in patients with familial hypercholesterolemia: Results from the SAFEHEART study
- Atherothrombosis
- Ticagrelor versus clopidogrel in myocardial infarction patients with high bleeding riskrisk: A report from the SWEDEHEART registry
- Ticagrelor vs clopidogrel use in high bleeding risk in hospitalized patients with acute coronary syndrome: findings from the CCC–ACS project
- Long-term clopidogrel monotherapy vs prolonged DAPT beyond 12 months after PCI in high-risk patients
- Meta-analysis of 8 studies (N=29,217) on DAPT in elderly CAD patients published 2007-2020.
- Findings from extended study in patients with CAD
- De-escalation strategies in anti-platelet therapy: Understanding when to switch from a potent agent
- Post-hoc analysis of the HOST-EXAM extended study assessing the effect of age on antiplatelet monotherapy during chronic maintenance post-PCI
- Acute coronary syndrome
- Exploring Dual Antiplatelet Therapy Approaches in Acute Coronary Syndrome
- Charting the Course of Antiplatelet Therapy in Elderly ACS Patients
- Charting the Course of Antiplatelet Therapy in ACS Patients
- Evolving strategies in CAD Management
- Crossroads of Cardiovascular Care: Insights into PCI and AMI Treatment Strategies
- Optimizing Treatment Strategies in Acute Coronary Syndrome
- Enhancing Antiplatelet Therapy for Older Patients: Balancing Risks and Benefits
- De-Escalation Strategies, Gender Differences, and Monotherapy Efficacy
- Antiplatelet Therapy and Statin Strategies in ACS: A Deep Dive into Efficacy and Safety
- Advances in Antiplatelet Therapy: Improving Outcomes with Tailored Approaches
- Refining Dual Antiplatelet Therapy: Latest Evidence for Stroke and ACS
- ACS Management: Insights on Rare Cases and Emerging Predictors
- Clopidogrel: Rethinking Antiplatelet Strategies for Better Outcomes
- Optimizing Hypertension Management: Single-Pill Combinations and Key Insights for Better Outcomes
- Evolving Insights on DAPT and SAPT: Highlights From Recent Key Trials
- Dual Therapy, FCAPs, and Antiplatelets: Recent Evidence You Should Know
- Thrombosis
- Central Nervous System
- Chronic Kidney Disease
- Consumer health
- Diabetes
- Early Detection Transforming Type 1 Diabetes Care in Children
- Empowering Diabetes Care: Cutting-Edge Technology and Patient-Focused Innovations
- Optimizing T2DM Management: Unlocking New Possibilities
- Critical Insights into Hypoglycemia and Diabetes Management
- Diabetes in Asians: Tailoring Management to Unique Metabolic Profiles
- Optimizing Diabetes Management: Insights on Therapeutic Use of the Fixed-Ratio Combination
- Managing Diabetes: Exploring Optimal Treatment Approaches
- Role of Biomarkers & Personalized Care in Diabetes Management
- Dive into diabetes management and basal insulin excellence secrets.
- Treatment advancement with basal insulin in people with T2D on prior GLP-1 RA therapy
- Exploring the Significance of Time in Range (TIR) for Glycemic Management
- The impact of early hypoglycemia
- Unlocking Insights in Diabetes Management during Ramadan
- Harnessing Technology for Better Outcomes in Diabetes Care
- Explore the importance of Time-in-range (TIR) and glycemic variability (GV)
- Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement
- Glycemic variability is an issue for DM patients.
- Expert panel recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with type 2 diabetes
- Fasting during Ramadan in T2DM patients
- Balancing glucose control & hypoglycemia in T2DM & CKD
- T1DM is associated with cognitive dysfunction
- T1DM is associated with cognitive dysfunction
- Asian T2DM patients may benefit from PPG control
- Simultaneous initiation had better glucose control
- Benefits and applications of TIR diabetes care
- Real world data on insulin treatment trends
- Commemorating insulin’s revolutionary discovery
- What should we seek in T2D therapy to address unmet patient needs?
- What is the "less is more" approach for T2D?
- Effectiveness of structured Ramadan nutrition plan in patients with type 2 diabetes using continuous glucose monitoring
- Old and new approaches to glycemic management in diabetes
- Are new-generation basal insulins truly better insulins?
- How Gla-300 has contributed markedly to patient convenience?
- Thrombosis
- RIETE registry : The world's largest database on patients with VTE
- LMWH : Antithrombotic choice with key features to diverse needs of your patient with active cancer
- VTE prophylaxis in general surgical patients
- Evidence based recommendations by EHA/ ESC in the management of antithrombotic treatments in thrombocytopenic patients with cancer
- What is Your Choice of Duration of Treatment for VTE Prophylaxis in High-risk Surgical Patients?
- Personalized approach for management of patients receiving anticoagulants for the treatment of cancer-associated thrombosis
- Incidence of venous thromboembolism with immune checkpoint inhibitors in a community setting: A single-center retrospective study.
- Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach
- Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
- Venous thromboembolism (VTE) in cancer patients is a major health burden
- Extended Venous thromboembolism treatment in patients with active cancer
- Vaccines
- Childhood
- Choosing Hexavalent Vaccine, a globally trusted aP vaccine. Offer the safety, e cacy, consistency & reliability of an ap vaccine.
- Choose aP vaccines for improved parents' satisfaction
- aP vs wP pertussis vaccines
- A randomized open-label trial Of 2-Dose or 3-Dose pre-exposure Rabies Prophylaxis among Thai children
- Hexavalent Vaccine is an Acellular Pertussis (aP) Vaccine based on highly purified, selected components of Bordetella Pertussis organisms.
- Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP~T vaccination at 2, 4 and 6 months¹
- A time and motion study of the fully-liquid hexavalent vaccine.
- Switching from wP to aP pertussis vaccine
- aP vs wP pertussis vaccines
- A time and motion study.
- Burden of Respiratory Syncytial Virus Infection During the First Year of Life.
- Economic Assessment of Incorporating the Hexavalent Vaccine as Part of the National Immunization Program of Peru
- Bordetella pertussis is a common pathogen in infants hospitalized for acute lower respiratory tract infection during the winter season
- Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States
- Maternal Vaccination and Infant Influenza and Pertussis
- Rates and risk factors of severe respiratory syncytial virus infection in 2008-2016 compared with 1986-1998
- Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations.
- Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022
- Rabies-Related Knowledge, Attitudes, and Practices among Primary School Students in Chonburi Province, Thailand
- Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in Southeast England, 2019
- Predominant role of Haemophilus influenzae in the association of conjunctivitis, acute otitis media and acute bacterial paranasal sinusitis in children.
- Cost-minimization and opportunity cost analysis of fully-liquid hexavalent and meningococcal vaccines in Spain
- Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China
- Prescribe with simplify schedule by choosing hexavalent Vaccine
- Vaccine Effectiveness against Pediatric Influenza-a-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, Vision Network
- Influenza Vaccination in Children with Pulmonary Disease During the Covid-19 Pandemic
- Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2022
- Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2022
- Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease in Children. Statement of the Spanish Society of Paediatric Infectious Disease (Seip)
- Effectiveness of Poliovirus Vaccines against Circulating Vaccine-Derived Type 2 Poliomyelitis in Nigeria between 2017 and 2022: A Case-Control Study
- Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children
- Cost-Effectiveness of Seasonal Influenza Vaccination of Children in China: A Modeling Analysis
- The Impact of Rsv Hospitalization on Children's Quality of Life
- Persistence of Antibodies 5 Years after Hepatitis B Vaccination in Preterm Birth Children: A Retrospective Cohort Study Using Real-World Data
- Uncovering the Burden of Influenza in Children in Portugal, 2008-2018
- Seroprevalence of Hepatitis A Virus Antibodies among Children and Adolescents Living in Northern Thailand: An Implication for Hepatitis A Immunization
- Influenza Vaccine Effectiveness among Children: 2011-2020
- Nirsevimab for Prevention of Hospitalizations Due to Rsv in Infants
- What is the benefit of the acP vaccine?
- Choose aP vaccinesto improve parent's satisfaction
- Effectiveness of Poliovirus Vaccines against Circulating Vaccine-Derived Type 2 Poliomyelitis in Nigeria between 2017 and 2022: A Case-Control Study
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- General
- A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly
- Epidemiology of Invasive Meningococcal Disease Worldwide from 2010-2019: A Literature Review
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- The Burden of Invasive Meningococcal Disease in the Netherlands, 2011-2020
- Real-World Impact and Effectiveness of Menacwy-Tt
- Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (Menacyw-Tt) in Individuals Ages 12 Months and Older
- Burden of Pertussis in Adults Aged 50 Years and Older: A Retrospective Database Study in England
- Meningococcal Disease in the Post-Covid-19 Era: A Time to Prepare
- Burden of Pertussis in Adults Aged 50 Years and Older: A Retrospective Database Study in England
- Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- Cost-Minimization and Budget Impact Analysis of a Hexavalent Vaccine in the Colombian Expanded Program on Immunization
- Influenza
- WHO recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere
- In patients with respiratory disease. Flu can have a devastating impact¹, ²
- Influenza vaccine in heart failure patients
- WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2022-2023
- Influenza vaccine in the patients with CVD
- Influenza vaccination is cost-effectiveness
- WHO recommended composition of influenza virus vaccines for use in the 2023 northern hemisphere
- WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2023-2024
- The impact of influenza vaccination on cardiovascular disease
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: Systematic Review and Meta-Analysis Update
- Enhanced Passive Safety Surveillance of High-Dose and Standard-Dose Quadrivalent
- Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Influenza Vaccination and Risk of Stroke in Women with Chronic Obstructive Pulmonary Disease: A Nationwide, Population-Based, Propensity-Matched Cohort Study
- High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 years: Can We Do Better? A Systematic Literature Review
- A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
- The impact of influenza vaccination on cardiovascular disease
- Influenza Vaccination and Hospitalization Outcomes Among Older Patients With Cardiovascular or Respiratory Diseases
- How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population
- Influenza circulating viruses, positivity rate and risk factors for influenza associated severe acute respiratory infection during 2018/2019 winter season, Yemen
- A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections
- Global, Regional and National Estimates of Influenza-Attributable Ischemic Heart Disease Mortality
- Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics
- Correlation between Cardiovascular Protection and Influenza Vaccination
- High-Dose Influenza Vaccine Is Associated with Reduced Mortality among Older Adults with Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
- Burden of Influenza in the Elderly: A Narrative Review
- Cost-Effectiveness of Influenza Vaccination with a High Dose Quadrivalent Vaccine of the Elderly Population in Belgium, Finland, and Portugal
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
- Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass
- Global Burden of Influenza Lower Respiratory Tract Infections in Older People from 1990 to 2019
- Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
- Cost-Effectiveness of High-Dose Quadrivalent Influenza Vaccine Versus Standard-Dose Quadrivalent Influenza Vaccine for Older People in a Country with High Influenza Vaccination Rate
- Influenza Vaccination for Elderly, Vulnerable and High-Risk Subjects: A Narrative Review and Expert Opinion
- Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan
- Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study.
- The Association between Influenza Vaccine and Risk of Chronic Kidney Disease/Dialysis in Patients with Hypertension
- Estimated Health and Economic Impact of Using High-Dose Influenza Vaccine on Respiratory and Circulatory Plus Respiratory Hospitalizations of Older Adults in Australia
- Effectiveness of Influenza Vaccination against Coronavirus Disease (Covid)-19 Outcomes in Hospitalized Individuals in Brazil: An Epidemiological Study
- A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections
- Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation
- Influenza Vaccination and Major Cardiovascular Risk: A Systematic Review and Meta-Analysis of Clinical Trials Studies
- Smoking Cessation and Influenza Vaccination Can Reduce the Healthcare Burden of Copd
- Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
- Cardiologists' Knowledge and Perceptions of the Seasonal Influenza Immunisation
- Cardioprotective Effects of Influenza Vaccine
- Influenza Vaccination in Older Adults and Patients with Chronic Disorders: A Position Paper from the Portuguese Society of Pulmonology, the Portuguese Society of Diabetology, the Portuguese Society of Cardiology, the Portuguese Society of Geriatrics and Gerontology, the Study Group of Geriatrics of the Portuguese Society of Internal Medicine, and the Portuguese Society of Infectious Diseases and Clinical Microbiology
- Immunogenicity and Reactogenicity of Coadministration of Covid-19 and Influenza Vaccines
- Effectiveness of High-Dose Vs. Standard-Dose Quadrivalent Influenza Vaccine against Recurrent Hospitalisations and Mortality in Relation to Influenza Circulation: A Post-Hoc Analysis of the Danflu-1 Randomised Clinical Trial
- Impact of Influenza Vaccination History in the Clinical Course of Older Adults Hospitalized with Covid-19
- Rates of Severe Influenza-Associated Outcomes among Older Adults Living with Diabetes-Influenza Hospitalization Surveillance Network (Flusurv-Net), 2012- 2017
- Efficacy and Prolonged Safety of Haemophilus Influenzae Type B Conjugate Vaccines
- Summary of the National Advisory Committee on Immunization (Naci) Statement-Recommendation on Repeated Seasonal Influenza Vaccination
- Effect of influenza on outcomes in patients with heart failure.
- WHO recommended composition of influenza virus vaccines for use in 2024-2025 northern hemisphere
- Influenza Vaccine Effect on Risk of Stroke Occurrence: A Systematic Review and Meta-Analysis
- Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- Enhanced Passive Safety Surveillance of High-Dose and Standard-Dose Quadrivalent Inactivated Split-Virion Influenza Vaccines in Germany and Finland During the Influenza Season 2021/22
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Pregnancy
- Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis
- Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
- Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis
- Cost-Effectiveness Analysis of Seasonal Influenza Vaccination During Pregnancy: A Systematic Review
- Effectiveness of Maternal Influenza Vaccination During Pregnancy against Laboratory-Confirmed Seasonal Influenza among Infants under 6 Months of Age in Ontario, Canada
- Maternal Vaccination: Shaping the Neonatal Response to Pertussis
- Safety of Influenza Vaccination During Pregnancy: A Systematic Review
- The Current State of Pertussis Vaccination in Pregnancy around the World, with Recommendations for Improved Care: Consensus Statements from the Global Pertussis Initiative
- Childhood
- Rare Diseases
- Events
- Upcoming Events
- Past Events
- Diabetes
- Cardiovascular
- Central Nervous System
- Neurology
- Vaccines
- Ready to Use Hexavalent Vaccine – A Decade of Confident in Childhood Prevention
- Influenza Vaccine Masterclass 2024
- RTE Differences between wP vs aP vaccines
- Ready to Use Haxavalent Vaccine: A Decade of Confident in Childhood Prevention
- Impact of flu in adult patient and the legend of flu vaccines
- The Importance of Flu Vaccination and Effective Communication
- Immunology
- Pre-Recorded webinar
- Central Nervous System
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (part 1)
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (Part 2)
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (Part 3)
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (Part 4)
- Epilepsy webinar series: Episode 5 - A Pharmacological series
- Epilepsy webinar series: Episode 6 - A drug-resistant epilepsy series
- Epilepsy webinar series: Episode 7 - A special population series
- Epilepsy webinar series: Episode 8 - A series of standard vs new anti-seizure medications
- Epilepsy webinar series: Episode 9 - A series of epilepsy comorbidities
- Epilepsy webinar series: Episode 10 - A series of interesting case discussion
- Epilepsy webinar series: Episode 11 - Misdiagnosis of epilepsy series
- Epilepsy webinar series: Episode 12 - Medical management of SE: ER to ICU
- Epilepsy webinar series: Episode 13 - Sudden unexpected death in epilepsy: What we should know to provide better informed advice on SUDEP
- Diabetes
- Central Nervous System
- Upcoming Events
- Take a break
- Diabetes Café Series
- Diabetes café the series: EP.10 Matcha Affogato - beyond HbA1c, indulging time-in-range concept
- Diabetes café the series: EP.9 Mango passion fruit smoothies - Fruitful data and careful selection for older people
- Diabetes café the series: EP.8 Green tea latte - Balanced sweet in renal deficiency
- Diabetes café the series: EP.7 Caffe’ Misto - Simultaneous approach of brew coffee and streamed milk
- Diabetes café the series: EP.5 Caffe’ Mocha - Hot chocolate with hot cardiovascular outcome
- Diabetes café the series: EP.4 Caffe’ Latte -Fresh milk and clinical implication of soliMix trial
- Diabetes café the series: EP.3 caramel macchiato - fascinating taste of soliMix results
- Diabetes café the Series: EP.2 Cappuccino - RCTs with pragmatic milk foam
- Diabetes café the series: EP.1 espresso - Bitter of premix unmet need
- VacciCast
- ประสิทธิภาพป้องกัน admit ของวัคซีนไข้หวัดใหญ่ 4 สายพันธุ์
- ไข้หวัดใหญ่ในผุ้ป่วยเบาหวาน ป้องกันได้ แค่ฉีดวัคซีน
- คลายความสงสัย! ฉีดวัคซีนไข้หวัดใหญ่ไม่ตรงสายพันธุ์ ลดโอกาศติดเชื้อรุนแรงได้?
- Traveler Vaccine - IDAT Vaccine Recommendations 2023
- Combination Vaccine - Benefits in Clinical Practice
- QIV HD vs QIV SD
- Safety Profile
- IMD - Introduction
- IMD - Hajj and Umrah
- IMD - Vaccine and Recommendations
- Combination Vaccine – Pertussis Control
- Meningococcal Vaccines
- WHO Global Meningococcal Initiative
- Influenza and cardiovascular event
- Sequential Polio vaccine regimen
- Best time to vaccinate against influenza
- Combination Vaccine – Values of aP Vaccine
- Influenza vaccination in diabetes patient
- FAQ Frequently ask questions about influenza vaccination
- Fully Liquid Hexavalent Vaccine
- วัคซีน MCVs… ป้องกันโรคไข้กาฬหลังแอ่น
- ผู้ปกครองควรรู้ วัคซีนรวมดีอย่างไร?
- แตกต่างแต่เกี่ยวข้องกัน โรคไข้หวัดใหญ่ส่งผลอย่างไร ต่อโรคหลอดเลือดหัวใจ
- Sequential Polio vaccine regimen
- Combination Vaccine – Values of aP Vaccine
- ฉีดวัคซีนป้องกันโรคไข้กาฬหลังแอ่น
- Influenza Vaccine Masterclass 2024
- ความปลอดภัยของ วัคซีนไข้หวัดใหญ่ชนิด High Dose
- วัคซีนไข้หวัดใหญ่ ตอบชัดทุกประเด็นในคลิปเดียว
- Diabetes Café Series
- Cutting Edge Science
- Patient Support
- Disclaimer
- Error 404
.jpg/jcr:content/image%20(17).jpg)
